Evidence map›Paper›PMID 15345033›Full record

ArticleBMC bioinformatics2004

SED, a normalization free method for DNA microarray data analysis.

Huajun Wang, Hui Huang

Abstract readValidation Study
In one paragraph

Article in BMC bioinformatics, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Huajun WangOscient Pharmaceuticals Corporation, 100 Beaver St, Waltham, Massachusetts 02453, USA. hw14@columbia.edu
Hui Huang

Funding

Integrated Methods to Discover Novel Disease PathwaysR44AG022242 · NIA · OSCIENT PHARMACEUTICALS CORPORATION · PI DEL MASTRO, RICHARD G · 2003 to 2005
$2.0M
NIA NIH HHS R44 AG022242NIA NIH HHS R44 AG022242-01
6 · The paper itself

Abstract

backgroundAnalysis of DNA microarray data usually begins with a normalization step where intensities of different arrays are adjusted to the same scale so that the intensity levels from different arrays can be compared with one other. Both simple total array intensity-based as well as more complex "local intensity level" dependent normalization methods have been developed, some of which are widely used. Much less developed methods for microarray data analysis include those that bypass the normalization step and therefore yield results that are not confounded by potential normalization errors.

resultsInstead of focusing on the raw intensity levels, we developed a new method for microarray data analysis that maps each gene's expression intensity level to a high dimensional space of SEDs (Signs of Expression Difference), the signs of the expression intensity difference between a given gene and every other gene on the array. Since SED are unchanged under any monotonic transformation of intensity levels, the SED based method is normalization free. When tested on a multi-class tumor classification problem, simple Naive Bayes and Nearest Neighbor methods using the SED approach gave results comparable with normalized intensity-based algorithms. Furthermore, a high percentage of classifiers based on a single gene's SED gave good classification results, suggesting that SED does capture essential information from the intensity levels.

conclusionThe results of testing this new method on multi-class tumor classification problems suggests that the SED-based, normalization-free method of microarray data analysis is feasible and promising.

Indexed as

Central Nervous System NeoplasmsFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticGenes, NeoplasmHumansLeukemiaLymphomaMaleNeoplasmsNormal DistributionOligonucleotide Array Sequence AnalysisOvarian NeoplasmsProstatic Neoplasms

Identifiers

PMID15345033
PMCPMC517708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.